Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy

Table 1

Clinical characteristics and levels of angiogenic and vasculogenic factors in 15 control patients.

Age (yr)/sex	Duration of symptoms (days)	Status of lens	Extent of detachment (quadrants)	VEGF (pg/mL); (detection limit: 9.0 pg/mL)	sVEGFR-2 (pg·mL) (detection limit: 4.6 pg/mL)	SCF (pg/mL) (detection limit: 9.0 pg/mL)	s-Kit (pg/mL) (detection limit: 65 pg/mL)	PGE2 (pg/mL) (detection limit: 25 pg/mL)	eNOS (pg/mL) (detection limit: 15 pg/mL)
78/M	4	Pseudophakic	2	19.3	837.4	ND	87	68.2	ND
60/F	3	Pseudophakic	2	38.8	161.2	ND	ND	78.8	ND
47/M	6	Pseudophakic	4	ND	1126.6	128.4	247	38	ND
48/F	5	Phakic	2	ND	1730.7	ND	ND	42.8	ND
59/M	3	Phakic	2	ND	1016.2	22.2	163	80.2	ND
38/F	14	Phakic	2	33.1	93	ND	ND	28.1	ND
40/M	5	Phakic	3	ND	915.3	59.1	135	20.7	ND
27/F	7	Phakic	2	ND	656.2	ND	224.9	70.8	ND
65/F	10	Pseudophakic	4	27.7	783	ND	173	63.9	ND
55/M	2	Phakic	2	26.4	304.4	ND	ND	45	ND
40/F	4	Aphakic	2	ND	912.5	ND	ND	61.3	ND
70/M	2	Pseudophakic	2	16.5	934.4	37.6	58	67.3	ND
74/M	3	Pseudophakic	1	21	664.4	ND	137	63.2	ND
63/M	2	Pseudophakic	2	30.8	140.7	ND	ND	80.3	ND
50/M	5	Pseudophakic	3	ND	731.2	76.7	ND	61.7	ND

VEGF: vascular endothelial growth factor; sVEGFR-2: soluble vascular endothelial growth factor receptor-2; SCF: stem cell factor; s-kit: soluble c-kit; PGE₂: prostaglandin E₂; eNOS: endothelial nitric oxide synthase; ND: not detected.